Bausch + Lomb to Showcase Eye Health Strategies at Investor Conferences
PorAinvest
viernes, 15 de agosto de 2025, 12:50 am ET1 min de lectura
BLCO--
The first conference is the J.P. Morgan European Leveraged Finance Conference, scheduled for September 3, 2025, in London, U.K. Executive Vice President and Chief Financial Officer Sam Eldessouky will participate in investor meetings at this event. The second conference is the Morgan Stanley Global Healthcare Conference, set for September 8, 2025, at 7:45 a.m. ET in New York, NY. Chairman of the Board and Chief Executive Officer Brent Saunders and Sam Eldessouky will engage in a fireside chat at this conference. A live webcast of the Morgan Stanley fireside chat will be available on the Bausch + Lomb Investor Relations website.
Bausch + Lomb, founded in 1853, has a comprehensive portfolio of approximately 400 eye health products, including contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices and instruments. The company operates with a global footprint, employing around 13,500 people in approximately 100 countries. Headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey, Bausch + Lomb is committed to protecting and enhancing the gift of sight for millions of people worldwide.
These conferences are an opportunity for investors to engage directly with Bausch + Lomb's leadership and gain a deeper understanding of the company's strategic initiatives and financial outlook.
References:
[1] https://www.businesswire.com/news/home/20250814107491/en/Bausch-Lomb-to-Participate-in-Upcoming-Investor-Conferences
Bausch + Lomb will participate in two investor conferences in September 2025, with top executives engaging in meetings and discussions in London and New York. The Morgan Stanley conference will be live webcast for viewing. The company, founded in 1853, has a portfolio of approximately 400 eye health products and a global presence with around 13,500 employees operating in around 100 countries.
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced its participation in two significant investor conferences in September 2025. The events will provide investors with opportunities to gain insights into the company's strategic direction and financial performance.The first conference is the J.P. Morgan European Leveraged Finance Conference, scheduled for September 3, 2025, in London, U.K. Executive Vice President and Chief Financial Officer Sam Eldessouky will participate in investor meetings at this event. The second conference is the Morgan Stanley Global Healthcare Conference, set for September 8, 2025, at 7:45 a.m. ET in New York, NY. Chairman of the Board and Chief Executive Officer Brent Saunders and Sam Eldessouky will engage in a fireside chat at this conference. A live webcast of the Morgan Stanley fireside chat will be available on the Bausch + Lomb Investor Relations website.
Bausch + Lomb, founded in 1853, has a comprehensive portfolio of approximately 400 eye health products, including contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices and instruments. The company operates with a global footprint, employing around 13,500 people in approximately 100 countries. Headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey, Bausch + Lomb is committed to protecting and enhancing the gift of sight for millions of people worldwide.
These conferences are an opportunity for investors to engage directly with Bausch + Lomb's leadership and gain a deeper understanding of the company's strategic initiatives and financial outlook.
References:
[1] https://www.businesswire.com/news/home/20250814107491/en/Bausch-Lomb-to-Participate-in-Upcoming-Investor-Conferences

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios